DCs as targets for vaccine design

References

• Shortman K, Caux C. Dendritic cell development: multiple pathways to nature's adjuvants. Stem Cells 1997;15:409–19.
   PubMed Web of Science ®Google Scholar
• Jonas N, O'Neill H. Manipulation of dendritic cells for immunotherapy of tumours. Today Life Sci 2000;Nov/Dec:42— 8.
   Google Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control ofimmunity. Nature 1998;392:245–52.
   PubMed Web of Science ®Google Scholar
• Banchereau J, Briere F', Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767 — 811.
   PubMed Web of Science ®Google Scholar
• Steinman R. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271 — 96.
   PubMed Web of Science ®Google Scholar
• Jung S, Unutmaz D, Wong P et al. In Vivo Depletion of CD11c±dendritic cells abrogates priming of CD8± T cells by exogenous cell-associated antigens. Immunio 2002;17:211–20.
   PubMed Web of Science ®Google Scholar
• Fanger NA, Wardwell K, Shen L et al. Type I (CD64) and type II(CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. y Immunol 1996;157:541–8.
   Google Scholar
• Esposito-Farese ME, Sautes C, de la Salle H et al. Membrane and soluble Fc gamma Rh/II modulate the antigen-presenting capacity of murine dendritic epidermal Langerhans cells for IgG-complexed antigens. yImmunol 1995;155:1725— 36.
   Google Scholar
• Reis e Sousa C, Stahl PD, Austyn JM. Phagocytosis of antigens by Langerhans cells in vitro. yExp Med 1993;178:509–19.
   PubMed Web of Science ®Google Scholar
• Castellino F', Boucher PE, Eichelberg K et al. Receptor-mediateduptake of antigen/heat shock protein complexes results in major histocompatibility complex Class I antigen presentation via two distinct processing pathways. 7Exp Med 2000;191:1957— 64.
   Google Scholar
• Arnold-Schild D, Hanau D, Spehner D et al. Cutting edge: receptor-mediated endocytosis of heat shock proteins by professionalantigen-presentingcells.yImmunol1999;162:3757— 60.
   Web of Science ®Google Scholar
• Platt N, da Silva RP, Gordon S. Class A scavenger receptors andthe phagocytosis of apoptotic cells. Biocbem Soc Trans 1998;26:639–44.
   PubMed Web of Science ®Google Scholar
• Delneste Y, Magistrelli G, Gauchat J et al. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immu-nity 2002;17:353–62.
   Google Scholar
• Valladeau J, Ravel 0, Dezutter-Dambuyant C et al. Langerin, anovel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunio 2000;12:71–81.
   Google Scholar
• Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex Class II compartment downregulation by cytokines and bacterial products. yExp Med 1995;182:389–400.
   PubMed Web of Science ®Google Scholar
• Jiang W, Swiggard WJ, Heufler C et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995;375:151— 5.
   PubMed Web of Science ®Google Scholar
• Guermonprez P, Valladeau J, Zitvogel L et al. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 2002;20:621–67.
   PubMed Web of Science ®Google Scholar
• Geijtenbeek TB, Kwon DS, Torensma R et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000;100:587— 97.
   PubMed Web of Science ®Google Scholar
• Geissmann F', Launay P, Pasquier B et al. A subset of human dendritic cells expresses IgA Fc receptor (CD89), which mediates internalization and activation upon cross-linking by IgA complexes. y Immunol 2001;166: 346— 52.
   Google Scholar
• den Haan JM, Bevan MJ. Constitutive versus activation-dependent cross-presentation of immune complexes by CD8 ± and CD8 dendritic cells in vivo. y Exp Med 2002;196:817–27.
   PubMed Web of Science ®Google Scholar
• Jurgens M, Wollenberg A, Hanau D et al. Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, Fc epsilon RI. y Immunol 1995;155:5184–9.
   Google Scholar
• Engering A, Cella M, Fluitsma D et al. Mannose receptor mediated antigen uptake and presentation in human dendritic cells. Adv Exp Med Biol 1997;417:183–7.
   PubMed Web of Science ®Google Scholar
• Edwards AD, Diebold SS, Slack EM et al. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha + DC correlates with unresponsiveness to imidazo-quinolines. Eur y Immunol 2003;33:827— 33.
   PubMed Web of Science ®Google Scholar
• Takeuchi 0, Akira S. Genetic approaches to the study of Toll-like receptor function. Microbes Infect 2002;4:887— 95.
   Google Scholar
• Norbury CC, Hewlett LJ, Prescott AR et al. Class I MHC presentation of exogenous soluble antigen via macro-pinocytosis in bone marrow macrophages. Immunio 1995;3:783–91.
   PubMed Web of Science ®Google Scholar
• Sallusto E Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000;18:593–620.
   PubMed Web of Science ®Google Scholar
• Inaba K, Metlay JP, Crowley MT, Steinman R. Dendritic cellspulsed with protein antigens in vitro can prime antigen specific MHC-restricted T cells in situ. y Exp Med 1990;172:631–40.
   PubMed Web of Science ®Google Scholar
• Caux C, Massacrier C, Dezutter-Dambuyant C et al. Human dendritic Langerhan's cells generated in vitro from CD34± precursors can prime CD4± T cells and process soluble antigen. yImmunol 1995;155:5427–35.
   Google Scholar
• Austyn JM. Death, destruction, danger and dendritic cells. Nat Med 1999;5:1232–3.
   PubMed Web of Science ®Google Scholar
• Jackson DC, Purcell AW, Fitzmaurice CJ et al. The central role of played by peptides in the immune response and the design of peptide based vaccines against infectious diseases and cancer. Current Drug Targets 2002;3:175–96.
   PubMed Web of Science ®Google Scholar
• Purcell AW, Zeng W, Mifsud NA et al. Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design. y Rept Sci 2003;9:255–81.
   Google Scholar
• Heath WR, Carbone FR. Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol 2001;1:126–34.
   PubMed Web of Science ®Google Scholar
• Bjorck P, Kincade PW. CD19± pro-B cells can give rise to dendritic cells in vitro. y Immunol 1998;161:5795–9.
   Google Scholar
• Izon DK, Rudd W, DeMuth WS et al. A common pathway for dendritic cell and early B cell development. y Immunol 2001;167:1387–92.
   Google Scholar
• Ardavi C, Wu L, Li CL, Shortman K. Thymic dendritic cells andT cells develop simultaneously in the thymus from a common precursor population. Nature 1993;362:761–3.
   PubMed Web of Science ®Google Scholar
• Asselin-Paturel C, Boonstra A, Dalod M et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2001;2:1144–50.
   PubMed Web of Science ®Google Scholar
• Nakano H, Yanagita M, Gunn MD. CD11c± B220±Gr-1± cellsin mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. y Exp Med 2001;194: 1171–8.
   Google Scholar
• Martin P, Del Hoyo GM, Anjuere F et al. Characterization of anew subpopulation of mouse CD8alpha± B220± dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 2002;100:383–90.
   PubMed Web of Science ®Google Scholar
• Arpinati M, Green C, Heimfeld S et al. Granulocyte colony stimulating factor mobilizes T helper 2 inducing dendritic cells. Blood 2000;95:2484–90.
   PubMed Web of Science ®Google Scholar
• Sato K, Yamashita N, Baba M, Matsuyama T Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 2003;101:3581–9.
   PubMed Web of Science ®Google Scholar
• Sato K, Yamashita N, Yamashita N et al. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunio) 2003;18:367–79.
   PubMed Web of Science ®Google Scholar
• Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997;90:3245–87.
   PubMed Web of Science ®Google Scholar
• Osugi Y, Vuckovic S, Hart DN. Myeloid blood CD11c(± )dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. Blood 2002;100: 2858–66.
   Google Scholar
• MacDonald KP, Munster DJ, Clark GJ et al. Characterization ofhuman blood dendritic cell subsets. Blood 2002;100:4512–20.
   PubMed Web of Science ®Google Scholar
• Smith CM, Belz GT, Wilson NS et al. Cutting edge: conven-tional CD8alpha± dendritic cells are preferentially involved in CTL priming after footpad infection with Herpes simplex virus-1. yImmunol 2003;170:4437–40.
   Web of Science ®Google Scholar
• Pooley JL, Heath WR, Shortman K. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8 dendritic cells, but cross-presented to CD8 T cells by CD8± dendritic cells. y Immunol 2001;166: 5327–30.
   Google Scholar
• Filippi C, Hugues S, Cazareth J et al. CD4± T cell polarizationin mice is modulated by strain-specific major histocompatibility complex-independent differences within dendritic cells. y Exp Med 2003;198:201–9.
   PubMed Web of Science ®Google Scholar
• Von Stebut E, Ehrchen JM, Belkaid Yet al. Interleukin 1 {alpha}promotes Thl differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice. y Exp Med 2003;198:191–9.
   Google Scholar
• Sigal LJ, Crotty S, Andino R, Rock KL. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 1999;398:77–80.
   PubMed Web of Science ®Google Scholar
• Liu YJ. Dendritic cell subsets and lineages, and their functions ininnate and adaptive immunity. Cell 2001;106:259–62.
   PubMed Web of Science ®Google Scholar
• Hochrein H, Shortman K, Vremec D et al. Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. yImmunol 2001;166:5448–55.
   Web of Science ®Google Scholar
• Diebold SS, Montoya M, Unger H et al. Viral infection switchesnon-plasmacytoid dendritic cells into high interferon producers. Nature 2003;424:324–8.
   PubMed Web of Science ®Google Scholar
• Agrawal A, Lingappa J, Leppla SH et al. Impairment of dendriticcells and adaptive immunity by anthrax lethal toxin. Nature 2003;424:329–34.
   PubMed Web of Science ®Google Scholar
• Belz GT, Behrens GM, Smith CM et al. The CD8alpha(± )dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. y Exp Med 2002;196:1099–104.
   PubMed Web of Science ®Google Scholar
• Hugues S, Mougneau E, Ferlin W et al. Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. Immunio 2002;16:169–81.
   PubMed Web of Science ®Google Scholar
• Bonifaz L, Bonnyay D, Mahnke K et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompat-ability complex Class I products and peripheral CD8+ T cell tolerance. y Exp Med 2002;196:1627–38.
   PubMed Web of Science ®Google Scholar
• Banchereau J, Paczesny S, Blanco P et al. Dendritic cells: controllers of the immune system and a new promise for immunotherapy. Ann NY Acad Sci 2003;987:180–7.
   PubMed Web of Science ®Google Scholar
• Blanco P, Palucka AK, Gill M et al. Induction of dendritic celldifferentiation by IFN-alpha in systemic lupus erythematosus. Science 2001;294:1540–3.
   PubMed Web of Science ®Google Scholar
• Mahnke K, Qian Y, Knop J, Enk AH. Dendritic cells, engineered to secrete a T-cell receptor mimic peptide, induce antigen-specific immunosuppression in vivo. Nat Biotechnol 2003;21:903— 8.
   PubMed Web of Science ®Google Scholar
• Steinman RM, Pope M. Exploiting dendritic cells to improve vaccine efficacy. 7 Clin Invest 2002;109:1519–26.
   PubMed Web of Science ®Google Scholar
• Fitzmaurice CJ, Brown LE, McInerney TL, Jackson DC. The assembly and immunological properties of non-linear synthetic immunogens containing T-cell and B-cell determinants. Vaccine 1996;14:553–60.
   PubMed Web of Science ®Google Scholar
• Fitzmaurice CJ, Brown LE, Kronin V, Jackson DC. The geometry of synthetic peptide-based immunogens affects the efficiency of T cell stimulation by professional antigen-present-ing cells. Int Immunol 2000;12:527— 35.
   PubMed Web of Science ®Google Scholar
• BenMohamed L, Wechsler SL, Nesburn AB. Lipopeptide vaccines-yesterday, today, and tomorrow. Lancet Infect Dis 2002;2:425— 31.
   Google Scholar
• Zeng W, Jackson DC, Murray J et al. Totally synthetic lipid-containing polyoxime peptide constructs are potent immuno-gens. Vaccine 2000;18:1031 — 9.
   PubMed Web of Science ®Google Scholar
• Zeng W Ghosh S, Lau YF et al. Highly immunogenic and totallysynthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines. 7 Immunol 2002;169:4905— 12.
   PubMed Web of Science ®Google Scholar
• Deliyannis G, Jackson DC, Ede NJ et al. Induction of long-termmemory CD8( ) T cells for recall of viral clearing responses against influenza virus. 7 Virol 2002;76:4212–21.
   PubMed Web of Science ®Google Scholar
• Chua BY, Healy A, Cameron PU et al. Maturation of dendriticcells with lipopeptides that represent vaccine candidates for hepatitis C virus. Immunol Cell Biol 2003;81:67— 72.
   PubMed Web of Science ®Google Scholar
• Takeuchi 0, Sato S, Horiuchi T et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. 7 Immunol 2002;169: 10— 4.
   Google Scholar